Skip to main content
. 2018 Nov 9;20(12):84. doi: 10.1007/s11926-018-0799-0

Fig. 2.

Fig. 2

Differences in patient characteristics between pivotal RP and biosimilar etanercept trials (ETN, etanercept RP)